Skip to content

ICH

ICH Q10 4.1

4. CONTINUAL IMPROVEMENT OF THE PHARMACEUTICAL QUALITY SYSTEM

Section text

Management Review of the Pharmaceutical Quality System Management should have a formal process for reviewing the pharmaceutical quality system on a periodic basis. The review should include:

(a) Measurement of achievement of pharmaceutical quality system objectives;

(b) Assessment of performance indicators that can be used to monitor the effectiveness of processes within the pharmaceutical quality system, such as:

(1) Complaint, deviation, CAPA and change management processes; (2) Feedback on outsourced activities; (3) Self-assessment processes including risk assessments, trending, and audits; (4) External assessments such as regulatory inspections and findings and customer audits.

Glossary terms that cite this clause

Source: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.